UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

Diabetes care, 2016-03, Vol.39 (3), p.337-344

2016

Volltextzugriff (PDF)

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

Diabetologia, 2014-01, Vol.57 (1), p.187-191

2014

Volltextzugriff (PDF)

Precision medicine in type 1 diabetes

Diabetologia, 2022-11, Vol.65 (11), p.1854-1866

2022

Volltextzugriff (PDF)

Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis

Diabetologia, 2020-06, Vol.63 (6), p.1258-1267

2020

Volltextzugriff (PDF)

The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions

Diabetes care, 2022-04, Vol.45 (4), p.994-1006

2022

Volltextzugriff (PDF)

Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes

Diabetes care, 2016-11, Vol.39 (11), p.1879-1888

2016

Volltextzugriff (PDF)

Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors

Diabetes care, 2015-02, Vol.38 (2), p.323-328

2015

Volltextzugriff (PDF)

C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase

Diabetes care, 2018-07, Vol.41 (7), p.1486-1492

2018

Volltextzugriff (PDF)

Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth

Diabetes care, 2022-05, Vol.45 (5), p.1124-1131

2022

Volltextzugriff (PDF)

Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis

Diabetologia, 2024-08

2024

Volltextzugriff (PDF)

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

Diabetes (New York, N.Y.), 2022-07, Vol.71 (7), p.1591-1596

2022

Volltextzugriff (PDF)

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

Diabetes care, 2021-08, Vol.44 (8), p.1826-1834

2021

Volltextzugriff (PDF)

Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis

Diabetic medicine, 2024-09, Vol.41 (9), p.e15394-n/a

2024

Volltextzugriff (PDF)

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes

Diabetes care, 2024-07, Vol.47 (7), p.1114-1121

2024

Volltextzugriff (PDF)

Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives

The journal of clinical endocrinology and metabolism, 2024-05

2024

Volltextzugriff (PDF)

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function

Diabetes care, 2020-10, Vol.43 (10), p.2362-2370

2020

Volltextzugriff (PDF)

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study

Diabetologia, 2024-06, Vol.67 (9), p.1865

2024

Volltextzugriff (PDF)

Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis

Current diabetes reports, 2017-12, Vol.17 (12), p.129-10, Article 129

2017

Volltextzugriff (PDF)

The clinical consequences of heterogeneity within and between different diabetes types

Diabetologia, 2020-10, Vol.63 (10), p.2040-2048

2020

Volltextzugriff (PDF)

New insights on the genetics of type 1 diabetes

Current opinion in endocrinology, diabetes, and obesity, 2019-08, Vol.26 (4), p.181-187

2019

Volltextzugriff (PDF)

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Diabetes care, 2019-02, Vol.42 (2), p.208-214

2019

Volltextzugriff (PDF)

Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes

Diabetic medicine, 2022-05, Vol.39 (5), p.e14814-n/a

2022

Volltextzugriff (PDF)

Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells

Diabetologia, 2020-12, Vol.63 (12), p.2605-2615

2020

Volltextzugriff (PDF)

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

Diabetologia, 2021-10, Vol.64 (10), p.2258-2265

2021

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBmj Open

Zeitschrift / SerieThe Lancet. Diabetes & Endocrinology

ThemaEndocrinology & Metabolism

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Diabetes
(27)
Diabetes Mellitus
(21)
Humans
(21)
Insulin
(16)
Peptides
(12)
Adult
(11)
Female
(11)
Male
(11)
Type 1 Diabetes
(10)
Beta Cells
(9)
Medicine
(9)
Young Adult
(9)
Autoantibodies
(8)
C-Peptide
(8)
Child
(8)
Diabetes Mellitus, Type 1 - Genetics
(8)
Medicine & Public Health
(8)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Precision medicine in type 1 diabetes

Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis

The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions

Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes

Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors

C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase

Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth

Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes

Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study

Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis

The clinical consequences of heterogeneity within and between different diabetes types

New insights on the genetics of type 1 diabetes

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes

Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

Aktive Filter

Suchergebnisse filtern